Proliferin-related Protein/Plfr Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # AF1527F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Proliferin-related Protein/Plfr
Glu26-Phe244
Accession # P04769
Glu26-Phe244
Accession # P04769
Specificity
Detects mouse Proliferin-related Protein/Plfr in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Proliferin-related Protein/Plfr Antibody [FITC]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Proliferin-related Protein/Plfr
Plfr is a secreted protein belonging to the somatotropin/prolactin family. It is expressed most abundantly in the fetal part of the placenta and has been shown to be a potent placental anti-angiogenic hormone.
Alternate Names
Plfr, PRP
Gene Symbol
PRL
Additional Proliferin-related Protein/Plfr Products
Product Documents for Proliferin-related Protein/Plfr Antibody [FITC]
Product Specific Notices for Proliferin-related Protein/Plfr Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...